Cogent Biosciences, Inc. — Director's Dealing 2020

Jun 11, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Unum Therapeutics Inc. (UMRX)
CIK: 0001622229
Period of Report: 2020-06-09

Reporting Person: Aldag Jorn (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-09	Stock Option (Right to Buy)	$0.63	A	14331	Acquired	2030-06-09	Common Stock (14331)	Direct

Footnotes

F1: This option shall vest in full on the earlier of (i) June 9, 2021, and (ii) the next annual meeting of the Issuer's stockholders.